NSC |
Compound |
Enrichment |
Correlation |
NSC 763646 |
(E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole |
4.35666174401502e-006 |
0.46767523 |
NSC 736081 |
4-morpholin-4-yl-6[(Z)-2-(5-nitro-thiophen-2-yl)ethenyl]-1,3 ,5-triazin-2-ylamine |
4.69612670285786e-005 |
0.3224902 |
NSC 733795 |
3-O-Methyl-16-formyl-17-(2'-furyl)estra-1,3,5(10),16-tetraen -3-ol |
5.09419714526527e-005 |
0.2229925 |
NSC 709437 |
Null |
5.30973832161747e-005 |
0.22999213 |
NSC 624657 |
ANTINEOPLASTIC-624657 |
6.74487631170136e-005 |
0.36735938 |
NSC 637411 |
Null |
6.74487631170136e-005 |
0.26668241 |
NSC 642947 |
Methanone, [3-(dibromomethyl)-6-chloroquinolin-2-yl] phenyl- |
6.74487631170141e-005 |
0.25071195 |
NSC 736118 |
3,4-Dihydroxy-N-(3'-methoxyestra-1',3',5'(10'),6'-tetraene-1 7'b-yl)cinnamide |
6.74487631170141e-005 |
0.12724651 |
NSC 77038 |
WR 141 |
6.74487631170141e-005 |
0.16806228 |
NSC 650792 |
1,4,7,10-Tetrathia-13-azacyclopentadecane, 13-[(4-methylphenyl)sulfonyl]- |
9.50639901764799e-005 |
-0.0043584544 |